SARS-CoV-2 variants and ending the COVID-19 pandemic

• Published in: The Lancet (British edition) Vol. 397; no. 10278; pp. 952 - 954
• Main Authors: Fontanet, Arnaud, Autran, Brigitte, Lina, Bruno, Kieny, Marie Paule, Karim, Salim S Abdool, Sridhar, Devi
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 13.03.2021; Elsevier Limited; Elsevier
• Subjects: Biological Specimen Banks; Biosurveillance; Cell-mediated immunity; Comment; Communicable Disease Control; Communicable Disease Control - methods; Coronaviruses; COVID-19; COVID-19 - transmission; COVID-19 Vaccines; COVID-19 Vaccines - therapeutic use; Databases, Genetic; Disease transmission; Functional testing; High income; Humans; Immunization; Infections; Life Sciences; Mutation; Pandemics; Proteins; Santé publique et épidémiologie; SARS-CoV-2; SARS-CoV-2 - pathogenicity; Severe acute respiratory syndrome coronavirus 2; Vaccines; Viral diseases; United Kingdom > UK; Brazil; South Africa

[...]the end of the pandemic is only possible when vaccines that are effective against circulating variants are distributed equitably across the world. [...]for surveillance of the circulation of SARS-CoV-2 variants, sharing of variant-specific PCR primers could help to monitor their spread, particu...